There are 2789 resources available
254P - Impact of palbociclib-dose reduction on survival: A retrospective cohort study
Presenter: Maria Luisa Romero Lagures
Session: ePoster Display
255P - Propreseer: A reliable, collaborative prognostic model for tamoxifen-resistance breast cancer
Presenter: Weiqi Nian
Session: ePoster Display
Resources:
Abstract
256P - PI3K mutation is associated with reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer
Presenter: Keechilat Pavithran
Session: ePoster Display
257P - Health-related quality of life (HRQoL) in the ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
Presenter: Sibylle Loibl
Session: ePoster Display
195P - A prognostic signature based on two-miRNA and pathological data in early-stage HER2+ breast cancer patients
Presenter: Anna Adam Artigues
Session: ePoster Display
196P - Targeting ESR1 in breast cancer treatment: Repurposing of statins
Presenter: Eva Rahman Kabir
Session: ePoster Display
197P - Application of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer
Presenter: Laura Sánchez Escudero
Session: ePoster Display
198P - Complications associated with prolonged GCSF with dose-dense EC chemotherapy for early breast cancer patients
Presenter: Taha Amir
Session: ePoster Display